BloG

The “Food Is Medicine” movement is an approach to health care that seeks to improve patients’ health through nutrition. ACHI Director of Research Antonije Lazic shares his notes on a study that evaluated the effects of a Food Is Medicine program on healthcare utilization and costs in Massachusetts.

The Centers for Medicare and Medicaid Services has announced the drugs it has chosen for the third round of price negotiations between Medicare and drug manufacturers, including for the first time several drugs administered in doctors’ offices and other outpatient settings.

As public and private payers decide whether to provide coverage for popular weight-loss drugs in the class known as glucagon-like peptide-1 receptor agonists, or GLP-1s, there are four key questions to consider.

Arkansas Business’ latest health care-focused issue features an executive Q&A with ACHI President and CEO Craig Wilson.

The United Health Foundation ranks Arkansas as the 49th healthiest state in the latest installment of its annual America’s Health Rankings report.

The Centers for Medicare and Medicaid Services has proposed limited implementation of two new Medicare payment models aimed at bringing domestic drug prices down and making them comparable with those of peer countries.

ACHI President and CEO Craig Wilson and other experts discuss the federal Rural Health Transformation Program and its potential impacts on Arkansas in the latest issue of the Journal of the Arkansas Medical Society.

The Trump administration has announced plans for a new voluntary payment model intended to increase access to GLP-1 drugs — a class of medications often used for weight loss and the treatment of diabetes and other chronic conditions — for certain Medicare and Medicaid beneficiaries.

In this blog post, we highlight several new state and federal health laws that will take effect in 2026 — bringing changes to coverage requirements, preventive services, and healthcare financing and delivery systems.